BRIEF published on 03/30/2026 at 15:19, 1 month 8 days ago Median Technologies obtient la certification ISO 13485:2016 ISO 13485:2016 Normes Réglementaires Logiciel Basé Sur L'IA Solutions En Oncologie Eyonis®
BRIEF published on 03/30/2026 at 15:19, 1 month 8 days ago Median Technologies Achieves ISO 13485:2016 Certification ISO 13485:2016 Regulatory Standards Oncology Solutions Eyonis® AI-based SaMD
PRESS RELEASE published on 03/30/2026 at 15:14, 1 month 8 days ago Inside Information / Other news releases Median Technologies achieves ISO 13485:2016 certification for eyonis® Medical Device Quality Management System, reinforcing commitment to safe and reliable oncology solutions Median Technologies AI-based Software Oncology Solutions ISO 13485:2016 Certification Eyonis Medical Device
BRIEF published on 02/12/2026 at 22:10, 2 months 23 days ago Median Technologies and Tempus Partner to Expand Lung Cancer Screening in the U.S. FDA Clearance Median Technologies Lung Cancer Screening Eyonis® LCS Tempus AI
BRIEF published on 02/12/2026 at 22:10, 2 months 23 days ago Median Technologies et Tempus s'associent pour étendre le dépistage du cancer du poumon aux États-Unis. Autorisation De La FDA Technologies Médianes Dépistage Du Cancer Du Poumon Eyonis® LCS Tempus IA
PRESS RELEASE published on 02/12/2026 at 22:05, 2 months 23 days ago Inside Information / Other news releases Median Technologies collaborates with Tempus to expand access to eyonis® LCS Software as a Medical Device in the US following FDA 510(k) clearance, enhancing lung cancer screening with AI tools FDA Clearance AI Tools Median Technologies Eyonis® LCS Tempus
PRESS RELEASE published on 02/12/2026 at 22:05, 2 months 23 days ago Informations privilégiées / Autres communiqués Median Technologies collabore avec Tempus pour distribuer le logiciel eyonis® LCS aux États-Unis, suite à l'obtention de l'autorisation FDA 510(k) pour le dépistage du cancer du poumon via Tempus Pixel Median Technologies Eyonis® LCS Tempus FDA 510(k) Dépistage Cancer
BRIEF published on 02/11/2026 at 17:50, 2 months 24 days ago Declaration of the Number of Voting Rights and Shares of Median Technologies Share Capital Voting Rights Treasury Shares Euronext Growth Median Technologies
BRIEF published on 02/11/2026 at 17:50, 2 months 24 days ago Median Technologies Announces Voting Rights Update Voting Rights Shares Treasury Shares Euronext Growth French Regulation
BRIEF published on 02/11/2026 at 17:50, 2 months 24 days ago Déclaration du Nombre de Droits de Vote et Actions de Median Technologies Droits De Vote Capital Social Euronext Growth Actions Auto-détenues Median Technologies
Published on 05/08/2026 at 01:50, 6 hours 58 minutes ago Apex Critical Metals Announces Grant of Stock Options and RSUs
Published on 05/08/2026 at 00:45, 8 hours 3 minutes ago Route1 Announces First Quarter 2026 Financial Results Notification
Published on 05/08/2026 at 00:00, 8 hours 48 minutes ago Redwood AI Approved to Receive National Research Council of Canada Funding for its Q-SAFE Chemical Screening Project for Defence and Security Applications
Published on 05/07/2026 at 23:30, 9 hours 18 minutes ago Faraday Copper Reports First Quarter 2026 Financial Results
Published on 05/07/2026 at 23:15, 9 hours 33 minutes ago BULGOLD Adopts Semi-Annual Financial Reporting
Published on 05/08/2026 at 08:30, 17 minutes ago Original-Research: Warimpex Finanz- und Beteiligungs-AG (von East Value Research GmbH ):
Published on 05/08/2026 at 08:30, 18 minutes ago ONATi/Vini strengthens customer protection: cyan AG becomes new cybersecurity partner in French Polynesia
Published on 05/08/2026 at 08:02, 45 minutes ago Commerzbank delivers strong first quarter and targets Net RoTE of 21% by 2030
Published on 05/08/2026 at 08:00, 47 minutes ago LIBERO to attend the World Football Summit in Madrid
Published on 05/08/2026 at 07:58, 50 minutes ago Commerzbank delivers strong first quarter and targets Net RoTE of 21% by 2030
Published on 05/07/2026 at 19:15, 13 hours 33 minutes ago 2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 13 hours 33 minutes ago Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 13 hours 42 minutes ago Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 13 hours 42 minutes ago Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 13 hours 48 minutes ago ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
